Twin Lakes Capital Management, LLC Ionis Pharmaceuticals Inc Transaction History
Twin Lakes Capital Management, LLC
- $144 Million
- Q2 2024
A detailed history of Twin Lakes Capital Management, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Twin Lakes Capital Management, LLC holds 1,500 shares of IONS stock, worth $58,140. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,500
Previous 1,500
-0.0%
Holding current value
$58,140
Previous $65,000
9.23%
% of portfolio
0.05%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding IONS
# of Institutions
390Shares Held
125MCall Options Held
2.25MPut Options Held
510K-
Vanguard Group Inc Valley Forge, PA13.8MShares$537 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD12.6MShares$490 Million0.38% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$400 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.26MShares$320 Million6.59% of portfolio
-
Wellington Management Group LLP Boston, MA6.57MShares$255 Million0.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.5B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...